IP Library Granted Patent US 8,114,401
Granted Patent B2
US 8,114,401 · App. 12/586,601 · Granted Feb 14, 2012

Patent

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,114,401
App. No.
12/586,601
Granted
Feb 14, 2012
Kind
B2
Abstract

Proteins encoded by Chlamydia trachomatis which are immunogenic in humans as a consequence of infection have been identified using Western blots of two-dimensional electrophoretic maps. Several known immunogens were identified, as were proteins not previously known to be immunogens, and proteins not previously reported as expressed gene products.

Claims (1)

1. A method of eliciting a Chlamydia trachomatis -specific immune response in a patient, the method comprising the step of administering to the patient an effective amount of an immunogenic composition consisting of an immunogenic protein comprising a Chlamydia trachomatis htrA protein having the N-terminal sequence as shown in SEQ ID NO: 3.